Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
3.350
-0.120 (-3.46%)
Aug 14, 2025, 11:52 AM - Market open
Kyverna Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$15.50
Upside
+362.69%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $4 → $5 | Hold → Strong Buy | Upgrades | $4 → $5 | +49.25% | May 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $6 → $4 | Hold | Maintains | $6 → $4 | +19.40% | Apr 3, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $40 → $20 | Buy | Maintains | $40 → $20 | +497.01% | Apr 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $7 → $6 | Hold | Maintains | $7 → $6 | +79.10% | Nov 20, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $44 → $24 | Buy | Maintains | $44 → $24 | +616.42% | Nov 15, 2024 |
| UBS | UBS | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | +288.06% | Oct 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $7 | Hold | Reiterates | $7 | +108.96% | Sep 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +108.96% | Aug 15, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $39 → $33 | Buy | Maintains | $39 → $33 | +885.07% | Jul 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $8 | Hold | Reiterates | $8 | +138.81% | Jul 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Initiates $8 | Hold | Initiates | $8 | +138.81% | Jul 3, 2024 |
| JP Morgan | JP Morgan | Buy Initiates $39 | Buy | Initiates | $39 | +1,064.18% | Mar 4, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $40 | Buy | Initiates | $40 | +1,094.03% | Mar 4, 2024 |